SCHEMBL24935012

SCHEMBL24935012

CC(=O)Cc1ccc(CC(=O)Nc2ccc(C)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.73
GAA P10253 2/20 0.73
RAB9A P51151 1/20 0.69
POLB P06746 2/20 0.61
EPHX2 P34913 2/20 0.60
NLRP3 Q96P20 1/20 0.59
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.54
LMNA P02545 1/20 0.53
RECQL P46063 1/20 0.53
KDM4E B2RXH2 1/20 0.53
HPGD P15428 1/20 0.53
CACNA1B Q00975 1/20 0.53
APBA1 Q02410 1/20 0.53
HSD17B10 Q99714 1/20 0.53
P2RY14 Q15391 1/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16542117 0.93 SMN1; SMN2 (0.83) SMN1; SMN2GAARAB9APOLBEPHX2
SCHEMBL24819419 0.90 SMN1; SMN2 (0.73) SMN1; SMN2GAARAB9APOLBEPHX2
SCHEMBL24935013 0.87 MEN1 (0.71) SMN1; SMN2GAARAB9APOLBEPHX2
SCHEMBL2456637 0.86 SMN1; SMN2 (0.73) SMN1; SMN2GAARAB9APOLBEPHX2
SCHEMBL10746702 0.85 MEN1 (0.71) SMN1; SMN2GAARAB9APOLBMEN1
SCHEMBL22758337 0.85 SMN1; SMN2 (0.71) SMN1; SMN2GAARAB9APOLBEPHX2
SCHEMBL17183464 0.85 SMN1; SMN2 (1.00) SMN1; SMN2GAARAB9APOLBEPHX2
SCHEMBL257816 0.84 EPHX2 (0.76) SMN1; SMN2GAARAB9APOLBEPHX2
SCHEMBL9312345 0.84 EPHX2 (0.76) SMN1; SMN2GAARAB9APOLBEPHX2
SCHEMBL24935402 0.83 NPC1 (0.71) SMN1; SMN2GAARAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4119546-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Suzhou Kintor Pharmaceuticals, Inc. (CN) 2023-01-18 EP disclosed